Your browser doesn't support javascript.
loading
Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID-19 pandemic.
Zhu, Jing; Rao, Gauri; Armistead, Paul M; Ptachcinski, Jonathan; Weiner, Daniel L; Wiltshire, Tim; Crona, Daniel J.
Afiliação
  • Zhu J; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
  • Rao G; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
  • Armistead PM; Division of Hematology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Ptachcinski J; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Weiner DL; Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, North Carolina, USA.
  • Wiltshire T; Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
  • Crona DJ; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.
Clin Transl Sci ; 15(3): 583-587, 2022 03.
Article em En | MEDLINE | ID: mdl-34743423

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacologia Clínica / Transplante de Células-Tronco Hematopoéticas / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacologia Clínica / Transplante de Células-Tronco Hematopoéticas / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article